Stay informed with the latest litigation news. Explore now

IP Verse

Troponin As Marker For Intermittent Atrial Fibrillation - EP3088900B1

EP3088900

F HOFFMANN LA ROCHE
Application Number
EP16175468A
Filing Date
Oct 17, 2012
Status
Revoked
Feb 23, 2024
Grant Date
Aug 12, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2464725B2
EP3559248B2
EP2296728B2

Bibliography

The patent EP3088900B1 was granted to F Hoffmann LA Roche on Aug 12, 2020 following the initial filing on Oct 17, 2012 under the application number EP16175468A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREMay 12, 2021 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents